Geron Corp (GERN) stock
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00+0.06 (+6.17%)
Close on Nov 17, 2026Market cap $642.47MP/E –Yield –
Geron price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Geron's price to sales ratio was 61.2× on Jan 31, 2025, against 403.0× a year earlier. Over the last 5 years it ranged from 8.1× to 499.5×, with a median of 255.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 61.2× | −14.3 |
| 2024 | Dec 31, 2024 | 75.5× | −378.8 |
| 2022 | Jul 29, 2022 | 454.3× | −45.2 |
| 2020 | Feb 28, 2020 | 499.5× | +116.3 |
| 2019 | Dec 31, 2019 | 383.3× | +190.9 |
| 2018 | Dec 31, 2018 | 192.4× | −103.6 |
| 2017 | Dec 29, 2017 | 296.0× | +243.3 |
| 2016 | Dec 30, 2016 | 52.7× | +31.5 |
| 2015 | Dec 31, 2015 | 21.2× | −375.7 |
| 2014 | Dec 31, 2014 | 396.8× | +49.7 |
| 2013 | Dec 31, 2013 | 347.1× | +268.6 |
| 2012 | Dec 31, 2012 | 78.5× | −35.2 |
| 2011 | Jul 29, 2011 | 113.8× | – |
See a number that looks wrong?